Detalles de la búsqueda
1.
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study.
JAMA Oncol
; 6(6): 831-838, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32379280
2.
Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial.
Lancet Gastroenterol Hepatol
; 3(4): 263-270, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29397354
3.
Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO.20 Trial.
J Clin Oncol
; 31(19): 2477-84, 2013 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23690424
4.
Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial.
J Clin Oncol
; 27(11): 1822-8, 2009 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19273701
Resultados
1 -
4
de 4
1
Próxima >
>>